Amanote Research
Register
Sign In
Pmu31 - A Review of Managed Access Agreements (Maas) and Patient Access Schemes (Pass) in England
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.1867
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
M Rahman
A Gapper
Publisher
Elsevier BV
Related search
Php365 - Trends and Characteristics of Managed Access Agreements Approved by Nice
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php296 - Managed Access Agreements (Maas) and Continuing Data Collection After Provisional Positive Recommendation From the National Institute for Health and Care Excellence (Nice)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Nice Patient Access Schemes – A Who, What, Why, When and How
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Nature of Endpoints in Market Access Agreements
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PCN157 Conceptual Framework for the Evaluation of Patient Access Schemes (PAS) in the EU
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Confidential Patient Access Schemes in the United Kingdom – Do They Affect Prices in Other Markets?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Monitoring Access to Nationally Commissioned Services in England
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
On Novel Access and Scheduling Schemes for IoT Communications
Mobile Information Systems
Computer Networks
Computer Science Applications
Communications
The Value of Market Access and National Treatment Commitments in Services Trade Agreements
OECD Trade Policy Papers
